Abstract-Despite the well-known role of the renin-angiotensin-aldosterone system (RAAS) in atheroma, its global local organization is poorly understood. In this study, we used transcriptomic meta-analysis to reveal the local transcriptional organization and regulation of 37 extended RAAS (extRAAS) genes in atheroma. Expression analysis and hierarchical clustering were done on extRAAS genes in 32 paired early and advanced atherosclerotic lesions. Contrary to receptorcoding transcripts, multiple angiotensin-metabolizing enzymes showed higher expression in advance, in comparison to early lesions. Interestingly, similar results were obtained from GEO data sets containing human (n=839) and mouse (n=18) atherosclerotic samples, but different from normal human (n=11) arterial tissues. The expression and coordination patterns were then used to construct transcriptional maps of extRAAS, displaying favored pathways in atheroma. Three coexpression modules (M1, M2, and M3) with >80% reproducibility across human atheroma data sets were identified. M1 and M3 contained angiotensin-metabolizing enzymes transcripts, whereas M2 contained proatherogenic receptorcoding transcripts. Interestingly, M1 and M2 were negatively correlated. A total of 21 transcription factors with enriched binding sites in the promoters of coordinated genes were extracted, among which IRF5, MAX, and ETV5 showed significant positive correlations with M1, but negative correlations with M2. However, ETS1 and SMAD1 transcripts were positively correlated to receptor-coding genes in M2. Despite sharing some similarities in extRAAS organization with kidney and adipose, atheroma showed specific correlations between extRAAS and transcription factors. In conclusion, our transcriptional map helps in designing more efficient treatments for atherosclerosis. In addition, the identified transcription factors provide a basis for the discovery of atheroma-specific modulators of extRAAS. 
A therosclerosis remains the leading cause of death and disability in developed countries. The importance of the renin-angiotensin-aldosterone system (RAAS) in the development of both atherosclerotic risk factors and atherosclerotic lesions has been experimentally and clinically documented. 1 In fact, RAAS has been shown to be locally expressed in the arterial wall 2 and to play major roles in atherosclerotic lesion initiation and progression through the modulation of endothelial dysfunction, inflammation, and vascular smooth muscle cell migration and proliferation. 1 Studies have shown that RAAS acts through 2 opposite arms in atherosclerotic lesions. The atheroprotective arm, defined by angiotensin (1-7) (Ang [1] [2] [3] [4] [5] [6] [7] ) and Ang-II, acts on Mas-1 receptor and Ang-II type 2 receptor (AT2R), respectively, 3 whereas the proatherogenic arm, defined by Ang-II and aldosterone, acts on Ang-II type 1 receptor (AT1R) and the mineralocorticoid receptor (MR), respectively. 1 Therefore, investigating RAAS at the tissue level would be better done in a systems biology approach that provides a better understanding of the various active pathways, and thus more specific and efficient targeted treatments. Mono-and combination therapies using angiotensin receptor blockers, angiotensin-converting enzyme inhibitors, and aldosterone antagonists play an important role in the prevention of atherosclerosis and in the delay of its progression. 4 However, a recent clinical trial suggests that combining angiotensin receptor blockers and angiotensin-converting enzyme inhibitors would lead to adverse side effects on kidney function. 5 Therefore, finding the tissue-specific characteristics of RAAS in atherosclerosis would provide the basis for a more tissue-specific treatment, with less side effects.
We have recently defined an extended RAAS (extRAAS) system containing 37 gene products 6 (Table S1 in the onlineonly Data Supplement). Using meta-analysis on transcriptomic data, we showed that this system has a tissue-specific organization characterized by specific patterns of expression and coordination. 6 Thus, we hypothesized that extRAAS has a specific organization in atheroma. In this study, a similar approach was used 6 to construct a map showing extRAAS organization in human atheroma plaques (ATHs). We then analyzed the promoters of coordinated extRAAS genes to identify candidate transcription factors (TFs) that regulate this organization and could be used as targets for future therapeutics.
Material and Methods

Microarray Experiments and Statistical Analysis
Our previously published microarray data set 7 was used to analyze the transcriptional expression and coordination of extRAAS genes. Briefly, a total of 64 Affymetrix arrays were performed on 32 patients in a pairwise manner: 32 ATH, corresponding to atherosclerotic lesion with Stary stage ≥4, and 32 macroscopically intact tissue (MIT) samples with Stary stage ≤2, 8 obtained from the same patients. Data were normalized with Affymetrix Expression Console software using the robust multiarray average method and were log2 transformed. Paired tests were used in the Significance Analysis of Microarrays (SAM) software to correct for multiple comparisons between MIT and ATH. Differences with local false discovery rate <5% were considered significant. The first tertile value of the microarray expression distribution was considered as the expression threshold (5.04 in MIT and ATH samples).
Downloading Public Microarray Data Sets
Published microarray data sets containing expression data for human and mouse atheroma were downloaded from the GEO database. Terms that were used to search for atherosclerotic samples were atherosclerosis, atheroma, blood vessel, artery, coronary, and carotid. Human carotid (n=300), human peripheral (n=539), and mouse aortic (n=18) atheroma samples were downloaded for analysis. Age, sex, ethnicity, medication, and clinical data were not taken into account in selecting the data sets from GEO database. Only data sets with more than 10 atheroma or normal samples were retained.
Expression Levels of extRAAS Genes in the Downloaded Data Sets
To compare expression data between multiple data sets that were normalized differently, gene expression levels were displayed using the expression centile rank. 6 The expression centile rank of a gene was obtained from the rank of its mean expression level relative to the mean expression data distribution over the microarray. When several data sets were present for the same tissue, mean expression centile rank (MCR) value was calculated across data sets.
Internal Organization of extRAAS Genes
In each data set, the internal organization of extRAAS was studied by hierarchical clustering of extRAAS genes from their log2-expression values across the samples.
Extraction and Analysis of Coordinated Genes' Promoters
Promoter sequences were only extracted for core promoters upstream to the first exon and for active alternative promoter regions. To identify over-represented transcription factor-binding sites (TFBSs) in the promoters of coordinated genes, promoter sequences of coordinated extRAAS genes were analyzed simultaneously using the CommonTF tool from Genomatix by applying default options.
Statistical Analysis
Expression results are represented as probe set intensity level±SEM for the MIT and ATH samples of the 64 microarray data set (GSE43292). Gene expression comparisons between MIT and ATH were performed using the SAM test for multiple comparisons in the 64-microarray data set, and differences of FDR<5% were considered significant. As for the downloaded data sets, each data set was considered one replicate for statistical comparisons. For centile rank expression levels, an expression centile rank was computed per data set and 1 MCR value was computed per tissue across data sets. Results are represented as individual data or as the MCR±SEM, SEM being computed across the data sets. One-sample signed-rank test was performed to compare between the 6 atherosclerotic data sets and the 1 normal arterial tissue data set. P values were adjusted for multiple comparisons using Benjamini-Hochberg correction. For gene coexpression, no correlation threshold was imposed in the hierarchical clustering process. Intracluster mean pairwise correlation coefficients were used to evaluate gene coexpression within data sets, and their significance were tested according to the sample size of the data set. In particular, the 2 subgroups of the 64-microarray data set, the correlation coefficient threshold was taken at r>0.35 (P<0.05). The average coordination rate (ACR) was used to evaluate gene coexpression across data sets. The ACR threshold was taken at 55% to select gene modules with more than half of their genes coclustered in all of the data sets.
Results
Expression and Clustering of extRAAS Genes in Human Carotid Atheroma
A total of 37 extRAAS genes were analyzed in this study (Table S1 ) using 64 Affymetrix arrays comparing ATH and MIT from 32 carotid endarterectomy patients (Table S2) . Multiple transcripts coding for angiotensin-metabolizing enzymes, including ACE, CMA1, CTSD, CTSG, DPP3, and MME, showed significantly higher expression in ATH compared with MIT ( Figure 1A ; Table S3 ). On the contrary, receptor-coding transcripts, AGTR1, EGFR, LNPEP, and NR3C2, showed a significant decrease in ATH compared with MIT.
Clustering analysis of extRAAS transcripts in ATH and MIT samples resulted in the dendrograms shown in Figure  1B . Two of the identified clusters were similar in the 2 tissue types. The first cluster grouped 10 strongly correlated transcripts with mean correlations r=0.66 (P=4.0×10 −5 ) in MIT and r=0.71 (P=5.3×10 −6 ) in ATH. This cluster, conserved in both tissue types, included transcripts coding for angiotensin-metabolizing peptidases whose expression increased in ATH compared with MIT. The second cluster associated the receptor-coding transcripts AGTR1, EGFR, LNPEP, NR3C1, and NR3C2, whose expression was lower in ATH compared with MIT, except for NR3C1. Interestingly, strong negative correlations were detected between the genes of the above 2 clusters in both the tissue types with mean correlations of r=−0.53 (P=0.0018) in MIT and r=−0.52 (P=0.0023) in ATH ( Figure 1B ).
Expression Levels and Clustering of extRAAS Transcripts From Public Atheroma Data Sets
To check for the reproducibility of our results, the expression and coordination of extRAAS genes were then analyzed in published microarray data sets available on the GEO database. The experimental work flow for the analysis of extRAAS genes in the downloaded atheroma data sets is shown in Figure 2 .
A total of 6 microarray data sets containing 839 human atheroma samples were downloaded (Table S4) , including our laboratory data set (GSE43292). Hierarchical clustering showed that all the 37 transcripts were strongly coordinated across all data sets with a mean agglomerative coefficient above 0.7. Interestingly, the clustering produced similar results, with minor disagreement, between public data sets and those obtained with our above described data set (GSE43292). Because there were 6 atheroma data sets, extRAAS modules of coexpressed genes were identified by calculating the ACR of genes across all data sets. A total of 4 coexpression modules were extracted with an ACR >80 ( Figure 3A) .
Of interest, the first module (M1) contained transcripts with high MCR, including 9 transcripts coding for angiotensin-metabolizing enzymes ( Figure 3A) . The second module (M2) comprised the receptor-coding transcripts, AGTR1, NR3C1, NR3C2, LNPEP, EGFR, and GPER, in addition to AGT, with an average intramodule MCR of 59±11 ( Figure  3A) . Interestingly, M1 and M2 revealed a negative intermodule correlation in 5 of the 6 data sets, corresponding to 810 of 839 samples.
However, only 1 data set including 11 normal human artery samples, which satisfies the stringent criteria set in our study, was available on the GEO database and hence analyzed (Table S4) . Three large clusters were identified with agglomeration coefficient equals to 0.86 ( Figure 3B ; Figure S1 ). In contrast to atheroma, the first cluster contained 10 transcripts encoding both enzymes and receptors, indicating a positive correlation between these enzymes and receptors.
ExtRAAS Transcriptional Maps
Construction of extRAAS maps was then performed using expression and coordination patterns (Figure 4) . The substrate of the system, AGT, was found to be highly expressed in both normal and atherosclerotic human arteries and could be metabolized into the 3 major bioactive peptides: Ang-II, Ang-IV, and Ang (1-7). However, the expression of angiotensin-metabolizing enzymes in atheroma ( Figure 4A ) was higher and more coordinated in comparison to normal arterial tissue ( Figure 4B ). Interestingly, strong correlations were present between the receptors in both normal and atherosclerotic samples. Moreover, the corticosteroid system was also more expressed in atheroma compared with normal arterial tissue. Another important feature found in both tissues was the absence of ACE2, AGTR2, and MAS1, the main participants of the atheroprotective Ang (1-7) pathway. Surprisingly, the major Ang-II-producing enzyme, ACE, was highly expressed in atheroma and coordinated with other peptidases ( Figure  4A ) but was missing in normal arterial tissue ( Figure 4B ).
Promoter Analysis of Coordinated Genes
A total of 38 promoters were extracted for the 31 genes, which belong to coordination modules in human atheroma (Table  S5 ). The mean number of extracted transcription site cluster per gene was 3±4. When no transcription site cluster could be extracted from SwissRegulon database for certain genes such as KLK1, CYP11B2, and CPA3, at least 1 transcription start site (TSS) could be extracted from the dbTSS database. The promoter GC content ranged between 29% and 75% with a mean of 55±12%. After extracting promoter sequences, common TFBSs over-represented in the promoters of coordinated genes were extracted using the CommonTF tool in the Genomatix suite. A total of 21 TFBS were extracted: 19 and 2 TFBSs were found to be enriched in the promoters of M1 and M2 atheroma gene modules, respectively (Table S6) . Interestingly, these TFBS were detected in the promoters of more than 80% of the corresponding genes. No TFBS could be extracted for the rest of the atheroma modules.
Expression Levels of TFs in Human Atheroma
TFs expression levels were compared between the 32 MIT and 32 ATH samples ( Figure 5A ; Table S7 ). Interestingly, all of these TFs were expressed above the tertile threshold in both tissue types. The following TFs were found to be significantly increased in ATH, compared with MIT: ETV5, MAX, ELK3, ELF1, SPIB, and IRF5.
The centile rank was also used to normalize the levels of TF transcripts in all the data sets ( Figure 5B ). Among the 21 TFs obtained, CDF1 and ZBTB14 were excluded from further analysis because they were not represented by any probe set in most of the microarray platforms. Interestingly, all TF transcripts had higher MCR than the first tertile in atheroma, except for SPIB ( Figure 5B ). However, in normal arteries, genes with expression less than the first tertile included SMAD1, MAX, ETS1, and FOXN1, which were overexpressed in atheroma (1.5-to 5-fold), in addition to ETV5 and IRF5 (1.8 fold). However, transcripts with ≈1.5-fold decrease included SPIB, IRF6, and SLC2A4RG ( Figure 5B ; Table S8 ). 
Clustering of extRAAS and TF Transcripts in Human Atheroma
Similar clustering results were obtained for extRAAS in human atheroma when TFs were added ( Figure 6A ; Table S9 ), in comparison to the clustering of extRAAS genes alone ( Figure 3 ). The first module (M1) included the same set of transcripts in addition to HSD11B1 and the 4 TFs: ELF1, ETV5, IRF5, and MAX ( Figure 6A) . Surprisingly, the latter 4 TFs were significantly increased in ATH, compared with MIT. Moreover, the same module of receptors (M2) was obtained, in addition to ENPEP, but without GPER ( Figure 6A ). It also included the 6 TFs: CTCF, ELK4, ETS1, IRF6, PAX9, and SMAD1 ( Figure 6A ).
Interestingly, transcripts coding for TFs and angiotensinmetabolizing enzymes in modules M1 and M3 showed significant negative correlations (P<0.01) with the receptor-coding transcripts of M2 and the corticosteroid enzymes-coding transcripts of M4 ( Figure 6B ).
ExtRAAS and TFs Coordination in Mouse Atheroma
One data set (GSE38574) containing 29 samples from atherosclerotic aortas of ApoE −/− mice was downloaded from the GEO database. Only 18 samples having medial expression levels were retained for further analysis. The data set was missing the probe sets for Akr1C4, Cyp21A2, Gper, Ren, Slc2A4Rg, and Znf76.
Interestingly, human and mouse atheroma showed the presence of a similar large module of enzyme transcripts, correlated with the 3 TFs: IRF5, ETV5, and MAX. In mouse atheroma, this module also included Cpa3 and Cma1, with the 3 TFs: Elk3, Egr1, and Egr3, which constituted a separate module in human atheroma (Table S9) . Another important similarity in atheroma of both species was the presence of a module that included the coordinated receptor transcripts NR3C1, NR3C2, AGTR1, and LNPEP (Table S9) .
Results obtained in both human and mouse atheroma were different from normal arterial tissue. For instance, the TFs, ETV5, MAX, and IRF5, that were coordinated with the large module of peptidases (M1) in both human and mouse atheroma were distributed over the different clusters in normal arterial tissue (Table S9) .
ExtRAAS and TFs Coordination in Kidney and Adipose Tissues
Because modules M1, M2, and M3 of extRAAS obtained in human atheroma shared some similarities to those previously obtained in normal human kidney and omental adipose tissue, 6 the coordination patterns of extRAAS with TF transcripts were also extracted for these tissues and compared with atheroma. Little, if any, similarities could be obtained in the coordination patterns between the atheroma and the kidney ( Figure 6A ; Table S9 ). However, similarly to human atheroma, 4 of the 6 TFs were also coordinated with receptors of M2 in normal omental adipose tissue ( Figure 6A ; Table S9 ). Indeed, normal adipose and human atheroma included a module containing AGTR1, LNPEP, NR3C1, NR3C2, and ENPEP and the 4 TFs: SMAD1, CTCF, ETS1, and ELK4.
Discussion
Although many studies were performed to elucidate the participation of extRAAS in atherosclerotic development, they gave no clear global view of the system organization in the disease. In this study, and for the first time, we used transcriptomic meta-analysis to map the local expression and coordination of 37 extRAAS transcripts, showing the favorable pathways, with highest expressed enzymes and receptors in atheroma. We also revealed potential TFs associated with coordinated extRAAS transcripts in atheroma.
Various complex approaches have been used to do coexpression meta-analysis, among which we used the pairwise gene coexpression across studies. 9 In this study, a simple method was chosen leading to the determination of the ACR index for each coexpression module. All extRAAS components were included in the clustering analysis regardless of their expression levels. Although the dependence on microarray platform for differentially expressed genes is not problematic, coexpression analyses require large sample sizes. 9 Thus, our meta-analysis aimed at exposing the most reproducible groups of coexpressed genes in atheroma across large data sets ranging between 11 and 290.
The expression map of extRAAS in atheroma shows that angiotensinogen (AGT), the substrate of the system, is expressed in human atheroma and could be metabolized to produce all known bioactive angiotensin peptides. This finding is in line with previous studies showing the expression of angiotensinogen in several arterial beds. [10] [11] [12] [13] Because it is difficult to acquire normal human arterial tissue, we compared the results obtained from atheroma lesions (ATH) to nearby macroscopically intact arterial tissue (MIT). 2 In addition, the importance of using paired ATH and MIT samples from the same patients is that it reduces clinical and demographic variabilities among individuals and increases the statistical power of differential gene expression. Although we could not observe significant difference in AGT expression between advanced ATHs and MIT, 12 previous data suggest that AGT expression is influenced by several factors, such as vascular injury, increased sodium diet, insulin resistance, and high cortisol. 2, [10] [11] [12] [13] This indicates that AGT is upregulated by atherosclerotic risk factors at the initial stages of atheroma development, thus enhancing atherosclerotic lesion initiation. Although renin transcripts were low in human atheroma, 12 its Ang-I-generating activity could be compensated for by other enzymes, such as cathepsin D and G, which are upregulated during atheroma progression. 12, 14 Renin could also be imported from the circulation by the highly expressed ATP6AP2 and IGF2R receptors, which were shown in previous studies to increase in atheroma and enhance renin activity. 14, 15 Our results also suggest that Ang-II may increase in advanced atherosclerotic lesions 16 as a result of the upregulation of Ang-II-generating enzymes, such as ACE, 12, 17 chymase, 16 catherpsin G, 12, 14 and cathepsin D.
14 Furthermore, the AT1R/AT2R ratio suggests that Ang-II acts mainly through AT1R in both MIT and ATH, 18, 19 thus favoring the proatherogenic effects of Ang-II over its atheroprrotective effects. Despite the upregulation in Ang (1-7)-generating enzymes, which may lead to increased Ang (1-7) levels, 20 its atheroprotective effects are masked as a result of the low levels of its receptors, AT2R and Mas1 receptor. 18, 19 The coordination of angiotensin-metabolizing enzymes involved in the generation of all angiotensin peptides indicates that production of these peptides is tightly regulated in atheroma, thus leading to a balance in the antagonistic pathways. Indeed, the local effects of the different bioactive pathways of the system are most probably differentiated at the response level by the differentially expressed receptors. In fact, this can be clearly demonstrated by the expression and high coordination of the proatherogenic receptor transcripts AGTR1, NR3C2, GPER, and EGFR, in contrast to the lower levels of the atheroprotective receptor transcripts AGTR2 and MAS1. In addition, the positive correlation between the proatherogenic receptor transcripts and AGT indicate that the system can maintain a proatherogenic state. Furthermore, despite the high levels of the atheroprotective glucocorticoid receptor GR (NR3C1) in both human and mouse atheroma, the high ratio of HSD11B1/ HSD11B2 observed in atheroma could exert the proatherogenic effects of cortisol, shown to bind MR (NR3C2) at high levels. 21 Although cortisol binding to MR may reduce the binding capacity of aldosterone, the latter can still exert its proatherogenic effects by binding to GPER, 22 which is expressed at sufficient levels in atheroma. Finally, our results indicate that Ang-IV pathway could also play a role in atheroma as suggested by the high expression of its enzymes and receptors.
Transcriptional regulation of multiple RAAS genes by TFs have been investigated by several studies, which focused on classical RAAS participants, mainly AGT, REN, ACE, and AGTR1. 23, 24 In this study, we propose several candidate TFs for the coordinate regulation of multiple extRAAS genes. The most relevant TFs obtained by our analysis in atheroma were IRF5, ETV5, ELF1, and MAX, which were not only positively correlated to angiotensin-metabolizing enzyme transcripts but also negatively correlated to the coordinated receptors. This was consistent with the negative correlation between the module of peptidases (M1) and the module of receptors (M2) in human atheroma, which strongly supports the role of these TFs in the extRAAS organization. However, the correlation of TFs to extRAAS genes with no corresponding promoter-enriched TFBSs indicates that there could be a DNA-independent link between TFs and extRAAS genes. In addition, these TFs may also have cis elements in distal promoters, several Kb away from the gene TSS, 25 and thus could be absent from the promoter regions we have analyzed.
Although these TFs are not validated in vivo or in vitro, we recently showed that the coordination between transcripts could be reproduced in cell culture as a result of common TFs activation. 26 Interestingly, a recent study showed that IRF5 deficiency may result in atheroma progression despite its wellknown proinflammatory records, 27 which could be indirectly related to its negative correlation with the receptors. However, the correlation of TFs to extRAAS genes with no corresponding promoter-enriched TFBSs indicates that there could be a DNA-independent link between TFs and extRAAS genes. In addition, these TFs may also bind to enhancer sequences that are several Kb away from the gene TSS, 25 and thus could be absent from the promoter regions we have analyzed.
Our results indicate that the organization of extRAAS in human atheroma is beyond the arterial bed of the atherosclerotic lesion, beyond interindividual variabilities. Indeed, we showed that extRAAS has similar expression patterns in atheroma from different arterial beds, known to respond in distinct ways to common risk factors associated with vascular disease, depending on their origins. 28, 29 In addition, our analysis was obtained regardless of patient medication 7 or atherosclerotic stage, which could point to stable features across atheroma development.
Interestingly, ApoE −/− mouse atheroma showed similar correlations between extRAAS and TFs in comparison to human atheroma. For instance, M3 in human atheroma that constitutes the EGR1, EGR3, and ELK3 TFs and the extRAAS transcripts CPA3, CMA1, and CTSG was totally joined into M1 in mouse atheroma, indicating a stringent correlation between these genes that could be atheroma related. Furthermore, the comparison of extRAAS and TF modules between atheroma, kidney, and adipose tissues indicated that the global tissuespecific organization of extRAAS could be, in part, related to tissue-specific transcriptional mechanisms. The similarity between atheroma and adipose tissue could be largely related to the adipose-like characteristics of lipid-storing cells in atherosclerotic lesions. Interestingly, the difference in correlations between atheroma and kidney could open the way for new atheroma-specific pharmaceuticals, with less side effects on kidney functions.
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Perspectives
We have established a coexpression map of extRAAS genes in human atheroma using transcriptomics data analysis and bioinformatics. This map suggests that all bioactive angiotensin peptides are produced in atheroma, and that the imbalance between the proatherogenic and atheroprotective effects of extRAAS could be mainly because of the imbalance at the receptor level, as manifested by the much higher transcript expression levels of proatherogenic receptors (AGTR1 and MR), in comparison to atheroprotective receptors (AGTR2 and MAS1). In addition, we have identified potential TFs that can regulate the expression of genes involved in certain pathways, which need to be validated in vitro and in vivo. Furthermore, the high similarity in the organization of extRAAS between human and mouse atheroma suggests that the mouse could be used as an in vivo model for studying extRAAS in atheroma. The identified TFs could be used as a tool to study the global expression of extRAAS in atheroma, which will help to better understand the involvement of ExtRAAS in atherosclerotic development, and thus provide novel therapeutics. What Is New?
• We have created, for the first time, a map of the transcriptional organization of 37 extRAAS genes, displaying favored pathways in human atheroma.
• In addition, we identified novel transcription factors that could play a role in the regulation of the global expression of extRAAS in atheroma.
What Is Relevant?
• extRAAS map in atheroma provides a reference for studying RAAS in atheroma and a frame for a more efficient and selective treatment of atherosclerosis.
• Similarly, the identified transcription factors will provide a basis for the discovery of new treatments, with less side effects.
Summary
Transcriptional map of coexpressed extRAAS genes in atheroma was created, which showed specific positive and negative correlations with certain transcription factors, compared with other tissues.
Novelty and Significance
Ali normalized by their authors, and those that lacked any transformation were log 2-transformed.
Expression levels of extRAAS genes in the downloaded datasets:
In order to compare expression data between multiple datasets that were normalized differently, gene expression levels were displayed using the expression centile rank (ECR) 6 . The ECR of a gene was obtained from the rank of its mean expression level relative to the mean expression data distribution over the microarray. When several datasets were present for the same tissue, mean ECR (MCR) value was calculated across datasets.
Internal organization of extRAAS genes:
In each dataset, the internal organization of extRAAS was studied by hierarchical clustering of extRAAS genes from their log2-expression values across the samples. The chosen method used Pearson correlation distance and the Ward's agglomerative method 7 (R software, "cluster" R library). The general Pearson correlation matrix for all of the extRAAS genes was computed for each dataset, and for each sample group of the GSE43292 dataset. The mean correlation coefficient between 2 gene clusters of size G1 and G2 was obtained by selecting the corresponding G1 x G2 subset of the correlation matrix and computing the mean intra-cluster pairwise correlation coefficients. Each of the dendrograms obtained was then cut at a given level to identify gene clusters. The cut-off level was chosen to balance between the clustering strength, assessed with the mean pairwise correlation coefficient, and a minimum of 3 gene transcripts per cluster. Since correlation coefficients between gene pairs often showed inconsistent results across datasets, only reproducible clusters of 2 or more genes across datasets were then extracted and called gene modules. The latter were assessed using the average coordination rate (ACR), which was calculated as the average percentage of co-clustered genes across all datasets. An ACR threshold >55% was used to define representative gene modules having more than half of their genes co-clustered in all datasets 6 .
Extraction and analysis of coordinated genes' promoters:: Promoter sequences were only extracted for core promoters upstream to the first exon and for active alternative promoter regions, i.e. when the expression of downstream exon is >1.5 folds greater than the upstream exon. For this, we used raw expression levels of individual probe sets of the GSE43292 dataset obtained in our laboratory. Transcription start clusters (TSC) were identified using the SwissRegulon human genome database 8 . After defining active TSCs, promoter sequences were extracted using the Genomatix database 9 . A promoter was defined by the sum of promoter sequences obtained by Genomatix around a specific TSC. When no Genomatix promoter sequence could be obtained for a specific TSC, the promoter sequence was extracted directly from the SwissRegulon genome viewer by including the region around the TSC with predicted transcription factor binding sites (TFBSs), usually spanning 400-700 bp upstream of the TSC and 100-500 bp downstream. Overlapping promoters for adjacent TSCs were joined in one promoter. Alternatively, the dbTSS database 10 was used to extract individual transcription start sites (TSSs) for certain genes for which no TSC could be found. For this, a promoter region including 500 bp upstream and 100 bp downstream the TSS (600 bp) was extracted using the NCBI genome viewer.
In order to identify over-represented TFBSs in the promoters of coordinated genes, promoter sequences of coordinated extRAAS genes were analyzed simultaneously using the CommonTF tool from Genomatix by applying default options 9 . All of the position-weight matrices (each one associated with one TFBS) having at least one match in the studied promoters were obtained with their enrichment p-value in the group of studied promoters. One TFBS was taken as significantly over-represented if its adjusted p-value (p-value/total 5 number of position-weight matrices having at least one match in the studied promoters) was < 0.05. Extraction of ECR for transcription factors in the datasets was done as previously mentioned. Clustering of extRAAS and TF transcripts was then done in order to identify gene coordination between them. 
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